tradingkey.logo

AVITA Medical Inc

RCEL

5.470USD

-0.070-1.26%
Cierre 09/19, 16:00ETCotizaciones retrasadas 15 min
145.58MCap. mercado
PérdidaP/E TTM

AVITA Medical Inc

5.470

-0.070-1.26%
Más Datos de AVITA Medical Inc Compañía
AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.
Información de la empresa
Símbolo de cotizaciónRCEL
Nombre de la empresaAVITA Medical Inc
Fecha de salida a bolsaMar 18, 2012
Director ejecutivoMr. James M. (Jim) Corbett
Número de empleados260
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 18
Dirección28159 Avenue Stanford
CiudadVALENCIA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal91355
Teléfono16613679170
Sitio Webhttps://www.avitamedical.com/
Símbolo de cotizaciónRCEL
Fecha de salida a bolsaMar 18, 2012
Director ejecutivoMr. James M. (Jim) Corbett
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. James M. (Jim) Corbett
Mr. James M. (Jim) Corbett
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Lou Panaccio
Mr. Lou Panaccio
Independent Non-Executive Chairman of the board
Independent Non-Executive Chairman of the board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. James M. (Jim) Corbett
Mr. James M. (Jim) Corbett
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
17.76M
95.91%
Japan
634.00K
3.42%
European Union (Region)
49.00K
0.26%
Australia
40.00K
0.22%
United Kingdom
35.00K
0.19%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: dom., 17 de ago
Actualizado: dom., 17 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
6.53%
The Vanguard Group, Inc.
5.45%
Geode Capital Management, L.L.C.
2.32%
State Street Global Advisors (US)
1.99%
UBS Financial Services, Inc.
1.54%
Otro
82.17%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
6.53%
The Vanguard Group, Inc.
5.45%
Geode Capital Management, L.L.C.
2.32%
State Street Global Advisors (US)
1.99%
UBS Financial Services, Inc.
1.54%
Otro
82.17%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
16.23%
Investment Advisor/Hedge Fund
7.95%
Hedge Fund
3.40%
Research Firm
1.31%
Individual Investor
0.91%
Venture Capital
0.11%
Bank and Trust
0.10%
Pension Fund
0.10%
Insurance Company
0.03%
Otro
69.86%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
210
7.20M
27.22%
-1.82M
2025Q1
225
7.35M
27.79%
-1.89M
2024Q4
218
6.78M
25.72%
-2.16M
2024Q3
215
6.40M
24.41%
-2.52M
2024Q2
210
6.40M
24.65%
-3.74M
2024Q1
216
7.55M
29.29%
-2.27M
2023Q4
213
7.36M
28.65%
-3.81M
2023Q3
208
8.37M
32.77%
-2.77M
2023Q2
206
8.16M
32.08%
-1.08M
2023Q1
205
7.71M
30.54%
-1.80M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
1.72M
6.52%
-20.83K
-1.19%
Mar 31, 2025
The Vanguard Group, Inc.
1.43M
5.42%
+10.39K
+0.73%
Mar 31, 2025
Geode Capital Management, L.L.C.
619.71K
2.34%
+22.11K
+3.70%
Mar 31, 2025
State Street Global Advisors (US)
526.95K
1.99%
-8.02K
-1.50%
Mar 31, 2025
UBS Financial Services, Inc.
344.73K
1.3%
+216.10K
+168.00%
Mar 31, 2025
Opaleye Management Inc.
440.00K
1.66%
+440.00K
--
Mar 31, 2025
Northern Trust Investments, Inc.
252.16K
0.95%
+38.49K
+18.02%
Mar 31, 2025
Wellington Management Company, LLP
82.21K
0.31%
+82.21K
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de sep
Actualizado: sáb., 6 de sep
Nombre
Proporción
ProShares Hedge Replication ETF
0.01%
Direxion Daily S&P Biotech Bull 3X Shares
0%
Avantis US Equity ETF
0%
Global X Russell 2000 Covered Call ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Pacer WealthShield ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
SPDR S&P Biotech ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
Ver más
ProShares Hedge Replication ETF
Proporción0.01%
Direxion Daily S&P Biotech Bull 3X Shares
Proporción0%
Avantis US Equity ETF
Proporción0%
Global X Russell 2000 Covered Call ETF
Proporción0%
DFA Dimensional US Sustainability Core 1 ETF
Proporción0%
Pacer WealthShield ETF
Proporción0%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0%
SPDR S&P Biotech ETF
Proporción0%
DFA Dimensional US Core Equity Market ETF
Proporción0%
Invesco Dorsey Wright SmallCap Momentum ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI